TNET Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TriNet Group Inc (TNET) is not a good buy at the moment for a beginner investor with a long-term strategy. The stock is currently in a bearish trend with weak technical indicators, declining financial performance, and mixed analyst sentiment. Despite some positive catalysts such as a stock repurchase program and hedge fund buying, the overall outlook is uncertain, and the stock does not align with the user's investment goals.
The stock is in a bearish trend with a negatively expanding MACD (-2.022), an oversold RSI (8.021), and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support levels are at S1: 43.479 and S2: 37.928, while resistance levels are significantly higher at R1: 61.453 and R2: 67.004. The current price of $40.05 is below key pivot levels, indicating further downside risk.
Hedge funds have significantly increased their buying activity, up 7443.06% over the last quarter.
TriNet announced a $400 million stock repurchase program, which could enhance earnings per share and boost shareholder confidence.
The company achieved 16% growth in free cash flow for 2025 and projects strong revenue for 2026.
The stock is in a bearish technical trend with oversold conditions and weak momentum.
Financial performance has significantly deteriorated, with revenue, net income, EPS, and gross margin all showing substantial YoY declines in Q4
Analysts have a Hold rating with reduced price targets, citing macroeconomic uncertainty and headwinds in insurance costs.
No recent congress trading data or influential figure activity to provide additional confidence.
In Q4 2025, TriNet's financial performance showed significant declines: Revenue dropped by 86.77% YoY, Net Income fell to $0 (down 100% YoY), EPS dropped by 795.65% YoY to 3.2, and Gross Margin turned negative (-546.75, down 4548.74% YoY). Despite beating EPS expectations for Q4 2025, the overall financial health is weak.
Analysts have a Hold rating on the stock. TD Cowen recently lowered its price target to $64 from $65, while Truist initiated coverage with a $62 price target, citing macroeconomic uncertainty and headwinds in insurance costs. Analysts expect the company to eventually recover but see timing as uncertain, leading to a cautious outlook.
